SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 4,600 shares, a growth of 170.6% from the November 30th total of 1,700 shares. Based on an average daily volume of 40,200 shares, the […]
Jefferies Financial Group lowered shares of SomaLogic (NASDAQ:SLGC – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports. Jefferies Financial Group currently has $2.30 price target on the stock, down from their prior price target of $3.50. Other research analysts have also issued research […]
Canaccord Genuity Group lowered shares of SomaLogic (NASDAQ:SLGC – Free Report) from a buy rating to a hold rating in a research report released on Monday morning, Marketbeat.com reports. Canaccord Genuity Group currently has $2.50 price objective on the stock, down from their prior price objective of $5.00. SomaLogic Stock Performance NASDAQ:SLGC opened at $2.36 […]
SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 7,700 shares, a decrease of 29.4% from the August 15th total of 10,900 shares. Based on an average daily volume of 4,500 shares, the […]
SomaLogic (NASDAQ:SLGC – Get Free Report) and Renalytix (NASDAQ:RNLX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Earnings and Valuation This table compares SomaLogic and Renalytix’s […]